Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Papillomavirus Infections 4Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Sarcoma 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Osteoporosis 1Neoplasms 1Melanoma 1Lung Neoplasms 1Infertility, Female 1Elective Surgery for Any Digestive Cancer 1Crohn Disease 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Cancer Ductal Infiltrating Metastatic 1Barrett Esophagus 1Airway Obstruction 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 4Imiquimod 3VGX-3100 2Conization 2Colposcopy 2Blood Specimen Collection 2lime 1hecolin 1Vaginal Smears 1Vaccines, Synthetic 1Spectrometry, Fluorescence 1Polymerase Chain Reaction 1Papillomavirus Vaccines 1Olive Oil 1Mass Screening 1Isotretinoin 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Hepatitis A Vaccines 1Fluorouracil 1Fenretinide 1Electroporation 1Cryosurgery 1AKAP13 protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Uterine Cervical Dysplasia × Blood Specimen Collection × Clear all
NCT03355820 2020-11-19

A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study

GlaxoSmithKline

Phase 3 Completed
228 enrolled 11 charts
Gynecologic

Uterine Cervical Dysplasia

NCT00929526 2016-10-20

Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study

GlaxoSmithKline

Phase 3 Completed
752 enrolled 21 charts
Gynecologic

Uterine Cervical Dysplasia, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡